Cargando…
Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI).
Induction of DNA damage by carcinogenic hexavalent chromium compounds [Cr(VI)] results from its reduction to lower oxidation states. Reductive metabolism of Cr(VI) generates intermediate Cr(V/IV)species, organic radicals, and finally Cr(III), which forms stable complexes with many biological ligands...
Autores principales: | Zhitkovich, Anatoly, Quievryn, George, Messer, Joseph, Motylevich, Zhanna |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1241234/ https://www.ncbi.nlm.nih.gov/pubmed/12426121 |
Ejemplares similares
-
Different ATM Signaling in Response to Chromium(VI) Metabolism via Ascorbate and Nonascorbate Reduction: Implications for in Vitro Models and Toxicogenomics
por: Luczak, Michal W., et al.
Publicado: (2015) -
The carcinogenicity of chromium
por: Norseth, Tor
Publicado: (1981) -
Chromium in Drinking Water: Sources, Metabolism, and Cancer Risks
por: Zhitkovich, Anatoly
Publicado: (2011) -
Chromium released from leather – I: exposure conditions that govern the release of chromium(III) and chromium(VI)
por: Hedberg, Yolanda S, et al.
Publicado: (2015) -
A possible role for chromium(III) in genotoxicity.
por: Snow, E T
Publicado: (1991)